Skip to main content

Table 2 Patient and clinical characteristics

From: A cross-sectional study on self-reported physical and mental health-related quality of life in rheumatoid arthritis and the role of illness perception

Variable Total population N = 120 (%)
Sex
 Female 99 (82.5)
 Male 21 (17.5)
Age
 <  45 years 29 (24.2)
 45–65 years 65 (54.2)
 >  65 years 26 (21.7)
Marital status
 Single 16 (13.3)
 Married 69 (57.5)
 Divorced/living separated 24 (20.0)
 Widowed 11 (9.2)
Educational level
 Compulsory/lower secondary 31 (25.8)
 Secondary school/apprenticeship 68 (56.7)
 Higher education 9 (7.5)
 Other 12 (10.0)
Monthly net income
 <  1.000€ (1120$) 23 (19.2)
 1.001–2000 € (1121–2240 $) 68 (56.7)
 2001–3000 € (224—3360 $) 20 (16.7)
 >  3000€ (>  3361$) 9 (7.5)
Disease duration
 >  10 years 35 (42.5)
 5–10 years 40 (33.3)
 1–4 years 34 (30.8)
 <  1 year 8 (6.7)
RA treatment
 NSAID 51 (42.5)
 sDMRAD 106 (88.3)
 bDMRAD 38 (31.7)
 Steroid 29 (24.2)
 Other 11 (9.2)
Additional medication
 No other medication 34 (28.3)
 1–2 other medications 45 (37.5)
 3–4 other medications 19 (37.5)
 >  4 other medications 22 (18.3)
Presence of co-morbidity 62 (51.7)
  Mean (SD)
Patient self–assessed (VAS) 37.8 (30.3)
 Disease activity 34.7 (29.4)
 Pain 40.8 (29.0)
 Functional disability 38.3 (31.0)
Fatigue
  1. NSAID non–steroidal anti–inflammatory drug, sDMRAD synthetic disease–modifying antirheumatic drug, bDMARD biologic disease–modying antirheumatic drug, VAS Visual analogue scale 0–100